ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Rocket Lab USA Inc

Rocket Lab USA Inc (RKLB)

24.00
-0.64
(-2.60%)
Closed January 18 4:00PM
24.24
0.24
(1.00%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

RKLB News

Official News Only

RKLB Discussion

View Posts
anesthesia doc anesthesia doc 17 hours ago
Bank of America analysts have identified Northrop Grumman (NOC), Booz Allen Hamilton (BAH), Rocket Lab (RKLB), Raytheon Technologies (RTX), and GE Aerospace (GE, Financial) as top defense stocks for 2025.

https://www.gurufocus.com/news/2659836/top-defense-stocks-for-2025-noc-bah-rklb-rtx-ge
👍️0
anesthesia doc anesthesia doc 18 hours ago
I wish I could say I timed it perfectly but I have been in the stock for over 2 years patiently waiting and adding when it dropped.
👍 1
BIOCHEMUP BIOCHEMUP 18 hours ago
78,000 shares? Wow
👍️0
anesthesia doc anesthesia doc 1 day ago
Don’t feel sorry for me. I have 78,000 shares at $6.80 a share. I’ll be okay if it retraces a little. I’m in it for 10 years, not 10 days like yourself.
👍️0
Laster Laster 1 day ago
LUNR trading better right now.
I go where the money takes me.
RKLB can’t hold $25.
It will need to find support at $22.50 and then $20. Worst case scenario is intra-day low of $18. I just don’t see any catalyst to move this back to $28-$30. Sorry my friend. It will be many months before it gets enough momentum to move back above $26.
JMO.
👍️0
anesthesia doc anesthesia doc 2 days ago
Do you even know anything about this company? Do you know what they have accomplished and what they are planning to do in the future?
👍️0
MasterSalix MasterSalix 2 days ago
You sound like a very short term momentum trader.  I used to trade like that - However, you make much more money picking good stocks and riding out the swings, rather than jumping in and off, but that is just my opinion.  I own the other two stocks you mentioned as well - at much lower levels, of course.
👍️ 1
Laster Laster 2 days ago
I guess just hope that the chart shows a reversal inverted hammer candle yesterday.
We will know by end of trading tomorrow.
Needs to move back to $26.50 to $27.
If this breaks $24 again then definitely it’s moving back to $20 or lower.
Huge gap at $15.
JMO.
👍️0
Laster Laster 2 days ago
Goldman Sachs target price increased to $13.50.
Usually target prices are higher than the current price.
Something strange is going on here that I just cannot figure out. I might have to re-evaluate my options since I am still in positive territory.
Maybe sell now and buy back when RKLB moves back to $20 or lower. Hmmmm……..
Not married to any of these stocks. They are just trades.
Sometimes, I have to change my views as market indicates a change in direction.
AI stock SOUN looks tempting at current prices.
👍️0
anesthesia doc anesthesia doc 2 days ago
“Significant weakness”? Are you being serious?
👍️ 1
MasterSalix MasterSalix 2 days ago
What did you buy at $30? Sitting on my $5s through this "weakness" lol .
👍️ 2
Laster Laster 2 days ago
Let’s see if this even closes green today.
ASTS and LUNR look good.
RKLB financing? Why so weak?
Retailers are usually last to know.
Something is causing significant weakness recently.
👍️0
Laster Laster 3 days ago
Clearly couldn’t hold $26 and now trying to support $25.
LUNR up 7% and RKLB barely up 3%.
Stock has topped out without a major catalyst.
Will likely continue lower until it finds support at $20.
I could be wrong. Hope I am. But, chart indicates weakness. Who knows.
Good luck.
👍️0
MasterSalix MasterSalix 3 days ago
Weakness? It is trading at $26 off an all time high of $30 - and a 52 week low of like $3.  We've come a long way and just because it isn't making new all time highs every day doesn't mean there is "weakness".  I wish all my stocks were as weak as to be up 800% on the year...
👍️ 2
Laster Laster 3 days ago
I have time. I bought Jan 2026 options several weeks ago.
But, still tough watching the stock show weakness which might last several months.
I think this market will drop 10% and rebound by April.
Hope I’m wrong.
👍️0
BIOCHEMUP BIOCHEMUP 3 days ago
See you in a few months and see where we are.
👍️0
BIOCHEMUP BIOCHEMUP 3 days ago
I don't know bro, these growth stocks take time. I think we will be alright.
👍️ 1
Laster Laster 4 days ago
Extremely weak since failed $30 break last week.
Mars event was a definite non event. Stock topped out at $29.50.
Broke $25 support like it wasn't there.
Now back under $24 heading toward $22.50 (which is 50-day moving average).
Huge gap at $15 that might close if this weakness continues for the next several months.
Sorry, but I just don't see this moving higher in the near future.
JMO.
👍️0
MasterSalix MasterSalix 4 days ago
Stock acting like one that went from $5 to $30 in 4 months.  Of course it is going to retrace.
👍️0
Laster Laster 4 days ago
Stock acting like a financing will be announced shortly.
I would expect it finance around $18-$20 but you never know.
Both ASTS and LUNR recovered today.
RKLB still trading near day low.
I expect it to retest $22.50 support and then likely back to $20 or lower.
The writing is on the wall.
JMO.
👍️0
Laster Laster 5 days ago
RKLB will follow the market lower unfortunately.
I think we see rough waters for awhile.
I will wait on the sidelines for things to settle.
It might get real ugly short term.
JMO.
👍️0
SilkRoad SilkRoad 5 days ago
Saw that. Love it.
👍️ 1 💯 1
BIOCHEMUP BIOCHEMUP 1 week ago
Stood it's ground pretty well after that market correction we had this week...
👍️ 1
Laster Laster 1 week ago
Market looks iffy for tomorrow but this is really good news IMO. Long term I see RKlB much higher than $30. Looking for $50 by summer. Good luck.
👍️ 1
double_m double_m 1 week ago
Rocket Lab Selected by NASA to Provide Neutron Launch Services Under VADR Launch Contract
January 09 2025 - 4:30PM
Business Wire

Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced a mutual agreement with NASA has been reached to include Neutron launch services to the agency through Rocket Lab’s existing VADR (Venture-Class Acquisition of Dedicated and Rideshare) contract.

Rocket Lab’s new medium-lift reusable rocket Neutron allows the opportunity for Rocket Lab to continue broadening access to space to deliver multiple missions across a range of orbits, including CubeSats, Class D missions, and other payloads. With its small orbital launch vehicle Electron already on-ramped for NASA’s VADR missions, Rocket Lab has previously demonstrated time-sensitive back-to-back launches within two weeks for the VADR PREFIRE missions and completed a similar fast turnaround of two launches in May 2023 for the VADR TROPICS missions.

https://ih.advfn.com/stock-market/NASDAQ/rocket-lab-usa-RKLB/stock-news/95224984/rocket-lab-selected-by-nasa-to-provide-neutron-lau
👍️ 1
WebSlinger WebSlinger 2 weeks ago
Rocket Lab USA, Inc. (NASDAQ:RKLB) shares are trading higher Monday following the announcement that the company will play a key role in Kratos Defense & Security Solutions (NASDAQ:KTOS) $1.45 billion MACH-TB 2.0 contract.

What To Know: Kratos, a defense technology company, on Monday secured a five-year contract for Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0, a project designed to enhance the U.S. hypersonic flight testing infrastructure.

The initiative, established under the Office of the Under Secretary of Defense for Research and Engineering’s National Hypersonic Initiative 2.0, aims to bridge the gap between ground testing and full-scale hypersonic system testing, reducing risks and accelerating development.

Kratos will lead Task Area 1 of the MACH-TB 2.0 project, focusing on systems engineering, integration and testing. Rocket Lab will provide air launch services as part of a larger team that includes Leidos, Stratolaunch and other subcontractors. This effort will support the increased frequency of hypersonic flight tests needed for national security objectives.

Kratos’ leadership emphasized the importance of the program in advancing affordable hypersonic technologies and highlighted the contract as the largest in the company’s history. The MACH-TB 2.0 program is expected to be a significant driver of future growth for Kratos, which also cited its existing hypersonic capabilities as a key factor in securing the contract.

"With the recent successes of our low-cost Erinyes Hypersonic Flyer and Zeus Solid Rocket Motors, Kratos is a leader in the testing and fielding of hypersonic systems. We are very excited to bring this unmatched expertise to the MACH-TB 2.0 program,” said Dave Carter, President of Kratos Defense and Rocket Support Services Division.

Rocket Lab shares are up nearly 200% over the past three months. The company reported better-than-expected financial results in mid-November and announced a multi-launch agreement with a confidential customer.

Rocket Lab guided for fourth-quarter revenue in the range of $125 million to $135 million. Rocket Lab is expected to report fourth-quarter earnings in February. Analysts currently expect the company to report a loss of 10 cents per share on revenue of $130.57 million, according to estimates from Benzinga Pro.
👍️0
MasterSalix MasterSalix 2 weeks ago
RKLB - $30 - gunna be a great year this year for RKLB - IMHO, GL2A
👍️ 1
rbtree rbtree 3 weeks ago
I am up ~160% on my 600 shares.

but, continuing with my LUNR call success (+$14k on paper since Mon am) I bought some Jan '26 $35 calls. Only 8, but what if we hit $50-100 by then? Plan is to hold them and the same exp LUNR calls for a year to save on cap gains.
👍️0
BIOCHEMUP BIOCHEMUP 3 weeks ago
I doubled down on rocketlab. 
👍️0
glenn1919 glenn1919 3 weeks ago
RKLB......................https://stockcharts.com/h-sc/ui?s=RKLB&p=W&b=5&g=0&id=p86431144783
👍️0
rbtree rbtree 3 weeks ago
paper gains on those calls ended up at close to 7000!
👍️0
rbtree rbtree 4 weeks ago
$200 may well be possible in 2-4 years!

Which means my current +115% gains could pale in comparison.

And why I may consider some 2025 calls, such as I bought yesterday of LUNR...and am already up $3000 on paper, of course.
👍️0
tw0122 tw0122 4 weeks ago
Off to Mars or Jupiter this round 
👍️0
glenn1919 glenn1919 4 weeks ago
RKLB....................https://stockcharts.com/h-sc/ui?s=RKLB&p=W&b=5&g=0&id=p86431144783
👍️ 1
miketherage miketherage 4 weeks ago
$250
👍️0
BIOCHEMUP BIOCHEMUP 4 weeks ago
Whats the price you have in mind? 
👍️0
SilkRoad SilkRoad 4 weeks ago
Mars bro. MARS!
👍️0
SilkRoad SilkRoad 4 weeks ago
The hats and coffee mugs are sold out again!
👍️0
SilkRoad SilkRoad 4 weeks ago
I think their products like what they produced for the Mars mission are being overlooked. As those missions to Mars achieve their objectives it will only bring more attention to RKLB. I have a price in my head if where I expect this stock to be in a couple years and there is a lot of room to grow in my opinion.
👍️0
SilkRoad SilkRoad 4 weeks ago
They’ve got t-shirts now with the missions on them. Those look cool. I don’t think I can get them in time for Christmas though. lol
👍️0
SilkRoad SilkRoad 4 weeks ago
Yes, RKLB investors, we just launched another rocket into Space. How cool is that? Watch …

👍️0
BIOCHEMUP BIOCHEMUP 1 month ago
Retracement looks done
👍️0
SilkRoad SilkRoad 1 month ago
Great Christmas gifts!
🎄 1 👍️ 1
TheDane TheDane 1 month ago
It’s nice to see someone really take a stand. LOL! Lots of ifs and maybes and coulds.
👍️0
anesthesia doc anesthesia doc 1 month ago
Rocket Lab just successfully launched their 3rd HASTE launch at 8pm EST today.
👍️0
anesthesia doc anesthesia doc 1 month ago
Good article:

https://pro.thestreet.com/trade-ideas/why-id-bend-the-rules-on-rocket-lab

Why I'd Bend the Rules on Rocket Lab
Here's my revised plan for this old 'Stocks Under $10' favorite.
Stephen GuilfoyleDec 10, 2024 10:15 AM EST

“ What Now?

You know I hate violating my net basis, but with this one, I see no choice if I want to grow the position. Our net basis stands at $5.05, which even after the drawdown puts us up almost 350%.

Readers will see that RKLB broke sharply out of that Andrews' Pitchfork model that I showed you last month. Relative Strength no longer stands in technically overbought territory. It's early, but the stock could be setting up what may end up being a bearish head and shoulders pattern. On top of that, below the chart, readers will see a now bearish looking daily Moving Average Convergence Divergence indicator.

Within that daily MACD, the histogram of the 9-day exponential moving average has gone negative, while the 12-day EMA has crossed under the 26-day EMA. We may get a chance to add to this long position lower or make a sale up here if that's what you're thinking. I am thinking of adding in between that 21-day EMA (currently $21.30) and the 50-day simple moving average (currently $15.10).

I don't think I need to even act unless the stock falls to those levels. I'll still panic (intentionally and planned, so it's not really a panic) if that 50-day line breaks. My Target price? Currently $33, and that's predicated on a new high being created that launches an algorithmic response. More than likely, the time is here to manage this position.”
👍️0
Laster Laster 1 month ago
Lots of morning selling on a daily basis. Will this hold that magic level $22.50?
Stock had really nice recovery end of day yesterday but looks weak again this morning.
I had options but sold them for HUGE profits and then moved into shares at $23.75.
I think I paid a huge premium especially if this stock covers that huge gap at $15.
But, I am willing to hold for $40 or higher in 2025.
👍️0
double_m double_m 1 month ago
Rocket Lab stock slips following insider selling
By Keith Noonan – Dec 8, 2024 at 9:15PM

Rocket Lab kicked off this past week's trading with a round of big selloffs following insider selling disclosures with the SEC. The company submitted filings on Nov. 27 that showed four company insiders had sold shares in the week of the filing. On Nov. 25, Chief Operating Officer Frank Klein, Chief Financial Officer Adam Spice, and General Counsel Arjun Kampani sold 35,968 shares, 62,511 shares, and 28,562 shares, respectively. The next day, board Director Merline Saintil sold 50,000 shares.

Rocket Lab then made additional filings with the SEC showing additional insider stock sales and purchases this week. On Dec. 2, board Director Alexander Slusky sold 50,000 shares. He then sold an additional 50,000 shares the following day.

On the other hand, CEO Peter Beck actually acquired 789,373 shares on Dec. 3. But the filings with the SEC suggest that the company stock Beck acquired was not purchased on the open market and instead received through stock options or bonus grants.
https://www.fool.com/investing/2024/12/08/why-rocket-lab-stock-sank-this-week/
👍️0
Monksdream Monksdream 1 month ago
RKLB, sold down from the 52;week high
👍️0
WebSlinger WebSlinger 1 month ago
Rocket Lab USA, Inc. (NASDAQ:RKLB) shares are trading higher on Friday.

The firm has announced the upcoming “Owl The Way Up” mission, set to launch on December 18th, 2024, from its Launch Complex 1 in Mahia, New Zealand.

This mission will deploy the latest satellite in Synspective’s growing Earth observation constellation.

The StriX satellite, designed to monitor millimetre-level changes to Earth’s surface using synthetic aperture radar (SAR), will be the sixth of 16 launches planned on Rocket Lab’s Electron rocket for the Japanese Earth observation company.

The partnership between Rocket Lab and Synspective began in 2020 and has flourished, with Rocket Lab serving as Synspective’s exclusive launch provider.

By flying dedicated missions instead of ridesharing, Rocket Lab allows Synspective to have greater control over their launch schedule and mission parameters, offering a unique level of flexibility for small satellite operators.

Rocket Lab’s founder and CEO, Sir Peter Beck, highlighted the strong relationship with Synspective, emphasizing their shared vision of enabling persistent monitoring of the planet.

“We’re looking forward to placing another StriX satellite in orbit and supporting Synspective’s vision to enable persistent monitoring of our planet to support disaster relief, agricultural development, maritime domain awareness and much more,” Beck said.

2024 has been a remarkable year for Rocket Lab, with 14 launches so far, surpassing its previous annual record of 10 missions in 2023.

According to Benzinga Pro, RKLB stock has gained over 428% in the past year. Investors can gain exposure to the stock via SPDR S&P Kensho Final Frontiers ETF (NYSE:ROKT).
👍️ 2